|
1
|
Su XL, Wang YF, Li SJ, Zhang F and Cui HW:
High methylation of the SEPT9 gene in Chinese colorectal cancer
patients. Genet Mol Res. 13:2513–2520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang XD, Xu XH, Zhang SY, Wu Y, Xing CG,
Ru G, Xu HT and Cao JP: Role of miR-100 in the radioresistance of
colorectal cancer cells. Am J Cancer Res. 5:545–559.
2015.PubMed/NCBI
|
|
3
|
Tang FR and Loke WK: Molecular mechanisms
of low dose ionizing radiation-induced hormesis, adaptive
responses, radioresistance, bystander effects, and genomic
instability. Int J Radiat Biol. 91:13–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo M and Dou J: Advances and perspectives
of colorectal cancer stem cell vaccine. Biomed Pharmacother.
76:107–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luckey TD: Physiological benefits from low
levels of ionizing radiation. Health Phys. 43:771–789. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feinendegen LE: Evidence for beneficial
low level radiation effects and radiation hormesis. Br J Radiol.
78:3–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Olivieri G, Bodycote J and Wolff S:
Adaptive response of human lymphocytes to low concentrations of
radioactive thymidine. Science. 223:594–597. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang G, Li W, Jiang H, Liang X, Zhao Y, Yu
D, Zhou L, Wang G, Tian H, Han F, et al: Low-dose radiation may be
a novel approach to enhance the effectiveness of cancer
therapeutics. Int J Cancer. 139:2157–2168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang X, Gu J, Yu D, Wang G, Zhou L, Zhang
X, Zhao Y, Chen X, Zheng S, Liu Q, et al: Low-dose radiation
induces cell proliferation in human embryonic lung fibroblasts but
not in lung cancer cells: Importance of ERK1/2 and AKT signaling
pathways. Dose Response. 14:15593258156221742016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shin YK, Yoo BC, Hong YS, Chang HJ, Jung
KH, Jeong SY and Park JG: Upregulation of glycolytic enzymes in
proteins secreted from human colon cancer cells with 5-fluorouracil
resistance. Electrophoresis. 30:2182–2192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hafner MF and Debus J: Radiotherapy for
colorectal cancer: Current standards and future perspectives. Visc
Med. 32:172–177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grem JL: 5-Fluorouracil: Forty-plus and
still ticking. A review of its preclinical and clinical
development. Invest New Drugs. 18:299–313. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sui X, Kong N, Wang X, Fang Y, Hu X, Xu Y,
Chen W, Wang K, Li D, Jin W, et al: JNK confers 5-fluorouracil
resistance in p53-deficient and mutant p53-expressing colon cancer
cells by inducing survival autophagy. Sci Rep. 4:46942014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Violette S, Poulain L, Dussaulx E, Pepin
D, Faussat AM, Chambaz J, Lacorte JM, Staedel C and Lesuffleur T:
Resistance of colon cancer cells to long-term 5-fluorouracil
exposure is correlated to the relative level of Bcl-2 and Bcl-X(L)
in addition to Bax and p53 status. Int J Cancer. 98:498–504. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei MF, Chen MW, Chen KC, Lou PJ, Lin SY,
Hung SC, Hsiao M, Yao CJ and Shieh MJ: Autophagy promotes
resistance to photodynamic therapy-induced apoptosis selectively in
colorectal cancer stem-like cells. Autophagy. 10:1179–1192. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de la Cruz-Morcillo MA, Valero ML,
Callejas-Valera JL, Arias-González L, Melgar-Rojas P, Galán-Moya
EM, García-Gil E, García-Cano J and Sánchez-Prieto R: P38MAPK is a
major determinant of the balance between apoptosis and autophagy
triggered by 5-fluorouracil: Implication in resistance. Oncogene.
31:1073–1085. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang G, Yu D, Li W, Zhao Y, Wen X, Liang
X, Zhang X, Zhou L, Hu J, Niu C, et al: Distinct biological effects
of low-dose radiation on normal and cancerous human lung cells are
mediated by ATM signaling. Oncotarget. 7:71856–71872.
2016.PubMed/NCBI
|
|
19
|
Brazina J, Svadlenka J, Macurek L, Andera
L, Hodny Z, Bartek J and Hanzlikova H: DNA damage-induced
regulatory interplay between DAXX, p53, ATM kinase and Wip1
phosphatase. Cell Cycle. 14:375–387. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin K, Adamson J, Johnson GG, Carter A,
Oates M, Wade R, Richards S, Gonzalez D, Matutes E, Dearden C, et
al: Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4
trial: Blockade at the level of p21 is associated with short
response duration. Clin Cancer Res. 18:4191–4200. 2012. View Article : Google Scholar : PubMed/NCBI
|
